Clinical trial
Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns
NCT00283426 · Biotec Pharmacon ASA, Industry · Terminated
Key facts
| NCT number | NCT00283426 |
|---|---|
| Title | Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns |
| Official title | An Open Clinical Feasibility Study to Evaluate Efficacy and Safety of Soluble Beta-1,3/1,6-Glucan in Thermal Burns |
| Lead sponsor | Biotec Pharmacon ASA, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Burns |
| Intervention type | Drug |
| Interventions | Soluble beta-1, 3/1, 6-glucan |
| Enrollment | 10 |
| Start date | Jan 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Jan 30, 2006 |
| Last update posted | Mar 19, 2007 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: